TITLE

Phosphatidylcholine Reduces Steroid Dependency in Ulcerative Colitis

AUTHOR(S)
Dye, Dayna
PUB. DATE
April 2008
SOURCE
Life Extension;Apr2008, Vol. 14 Issue 4, p18
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the outcome of the study conducted by German scientists on the ability of phosphatidylcholine to lessen steroid dependency in ulcerative colitis. The study reveals that phosphatidylcholine treatment can help patients with the inflammatory bowel disease, ulcerative colitis to be less dependent on steroid therapy. Up to 50% of the patients was able to withdraw from steroid treatment successfully and showed improved clinical activity.
ACCESSION #
31403943

 

Related Articles

  • A NOVEL INDEX TO ASSESS FUNCTIONAL SYMPTOMS IN INFLAMMATORY BOWEL DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA99 

    Functional symptoms occur in inflammatory bowel disease (IBD) probably more than in the general population. Existing disease indices lack objectivity, relying in port on the functional symptoms that overlap with organic disease manifestations. The article attempts to devise a structured...

  • PATIENTS' VIEWS OF THE INFLAMMATORY BOWEL DISEASE SERVICE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA110 

    Different means for outpatient services of inflammatory bowel disease follow up have been proposed. Four hundred and thirteen National Association for Colitis and Crohn's members responded, of which 237 patients had Crohn's disease and 176 ulcerative colitis. Patients are clearly interested in...

  • Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women. Zhenwu Lin; Poritz, Lisa; Franke, Andre; Tong-Yi Li; Ruether, Andreas; Byrnes, Kathryn A.; Yunhua Wang; Gebhard, Anthony W.; MacNeill, Colin; Thomas, Neal J.; Schreiber, Stefan; Koltun, Walter A.; Lin, Zhenwu; Li, Tong-Yi; Wang, Yunhua // Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p739 

    Purpose: To replicate the association of IL23R R381Q (rs11209026) with inflammatory bowel disease (IBD), examine the effect of the two nonsynonymous variations, Q3H and L310P, on IBD, and to study gender distribution of these variants in IBD patients.Results: IL23R...

  • Capsule endoscopy and enteroscopy: modern modalities to investigate the small bowel in paediatrics. Sidhu, R.; Sanders, D. S.; McAlindon, M. E.; Thomson, M. // Archives of Disease in Childhood;Feb2008, Vol. 93 Issue 2, p154 

    Historically the small bowel has been considered a technically difficult area to examine because of its length (3-5 metres), location and tortuosity. Capsule endoscopy and enteroscopy have revolutionised the investigation pathway of the small bowel in adults. They are now developing increasingly...

  • Steroid resistance in IBD: how big is the problem?  // Gut;Nov2006, Vol. 55 Issue 11, p1639 

    The article presents the study on the resistance of steroid in inflammatory bowel disease. Patients with ulcerative colitis and Crohn disease were evaluated, who were diagnosed at the Western General Hospital in Edinburgh, Scotland. The results show that corticosteroids are used for more often...

  • Mucosal Interleukin-8 Is Involved in Neutrophil Migration and Binding to Extracellular Matrix in Inflammatory Bowel Disease. Ina, Kenji; Kusugami, Kazuo; Yamaguchi, Takeo; Imada, Akira; Hosokawa, Takehiko; Ohsuga, Masahiro; Shinoda, Masataka; Ando, Takafumi; Ito, Katsuki; Yokoyama, Yasuhisa // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1342 

    Objectives: In this study, our purpose was to determine whether locally generated interleukin-8 (IL-8) is involved in neutrophil migration and binding to extra-cellular matrix, using the colonic mucosal specimens obtained from patients with inflammatory bowel disease (IBD). Methods: Levels of...

  • Sulfasalazine and New Analogues. Friedman, Gerald // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p141 

    Discusses research which focused on the use of sulfasalazine drugs for the treatment and prophylaxis of inflammatory bowel disease. Composition of the drug; Analysis of the efficacy of Pentasa in treating Crohn's disease; Contribution of Poly-ASA sulfasalazine oral formulation to the medical...

  • Can we prevent, reduce or reverse intestinal fibrosis in IBD? LATELLA, G.; SFERRA, R.; SPECA, S.; VETUSCHI, A.; GAUDIO, E. // European Review for Medical & Pharmacological Sciences;May2013, Vol. 17 Issue 10, p1283 

    Intestinal fibrosis is a common complication of in inflammatory bowel disease (IBD) and can occur in both ulcerative colitis (UC) and Crohn's disease (CD), but is much more prevalent in CD. Fibrosis is a consequence of local chronic inflammation and is characterized by abnormal deposition of...

  • Alleviation of Experimental Ulcerative Colitis with the Synthetic Peptide, F2A4-K-NS (Fibratide). Xinhua Lin; Paul Zamora; Kazu Takahashi; Yi Lui // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2054 

    Abstract  Recombinant fibroblast growth factors (FGFs) maintain the integrity of the gut epithelium and reduce mucosal injury in experimental inflammatory bowel disease (IBD). Chemically synthesized FGF mimetics could potentially extend the utility of FGFs by tailoring them for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics